Related Experiment Video
Updated: May 16, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Paracetamol in Pregnancy: Uncertain Evidence, Certain Consequences
David J Tunnicliffe1,2, Miranda Cumpston3, Debra Kennedy4,5
1School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
The Medical Journal of Australia
|May 14, 2026
Summary
A review falsely linked paracetamol use during pregnancy to autism. This analysis critiques the flawed review, highlighting how scientific uncertainty surrounding autism causes can be misused, causing public confusion about medication safety.
Area of Science:
- Public Health
- Epidemiology
- Medical Ethics
Background:
- Autism diagnoses have risen, sparking research into potential causes.
- A recent systematic review, based on observational studies, suggested a link between paracetamol and autism.
- This review has been cited publicly, causing concern regarding paracetamol safety during pregnancy.
Purpose of the Study:
- To critically appraise a systematic review linking paracetamol to autism.
- To examine the manipulation and amplification of scientific uncertainty in public health discussions.
- To address public confusion regarding paracetamol use in pregnancy.
Main Methods:
- Critical analysis of a systematic review's methodology and reporting.
- Examination of the evidence base for observational studies in relation to causality.
- Assessment of how scientific findings are presented and interpreted in the public domain.
Main Results:
- The cited systematic review exhibited selective reporting and methodological flaws.
- The review lacked sufficient causal evidence to support its conclusions.
- The review's conclusions have contributed to public confusion and anxiety.
Conclusions:
- The systematic review's conclusions regarding paracetamol and autism are not well-supported by the evidence presented.
- Scientific uncertainty can be exploited to create misleading public health narratives.
- Clearer communication and rigorous methodology are essential to prevent public confusion regarding medication safety in pregnancy.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...